| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 51,666 | 44,972 | 42,001 | 43,256 | | Cost of Revenue | 39,695 | 35,701 | 47,049 | 33,465 | | | Gross Profit | 11,971 | 9,271 | (5,048) | 9,791 | | | Operating Expenses | | Research Development | (706) | 706 | (5,684) | 1,688 | | Selling General and Administrative | 8,988 | 6,644 | 14,662 | 6,047 | | Non Recurring |
-
|
-
| 2,402 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,689 | 1,921 | (16,428) | 2,056 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16 | (19) | 200 | 344 | | Earnings Before Interest And Taxes | 3,705 | 1,902 | (16,228) | 2,400 | | Interest Expense |
-
|
-
| 173 |
-
| | Income Before Tax | 3,705 | 1,902 | (16,401) | 2,400 | | Income Tax Expense | 1,877 | 1,055 | (6,348) | 2,386 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,828 | 847 | (10,053) | 14 | | | Non-recurring Events | | Discontinued Operations | 90 | 85 | 400 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,918 | 932 | (9,653) | 14 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,918 | $932 | ($9,653) | $14 |
|
0.51% Nasdaq 0.00%
Income Statement
